Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Isolated congenital asplenia: a French nationwide retrospective survey of 20 cases.

Mahlaoui N, Minard-Colin V, Picard C, Bolze A, Ku CL, Tournilhac O, Gilbert-Dussardier B, Pautard B, Durand P, Devictor D, Lachassinne E, Guillois B, Morin M, Gouraud F, Valensi F, Fischer A, Puel A, Abel L, Bonnet D, Casanova JL.

J Pediatr. 2011 Jan;158(1):142-8, 148.e1. doi: 10.1016/j.jpeds.2010.07.027. Epub 2010 Sep 16.

PMID:
20846672
2.

Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness.

Lagresle-Peyrou C, Six EM, Picard C, Rieux-Laucat F, Michel V, Ditadi A, Demerens-de Chappedelaine C, Morillon E, Valensi F, Simon-Stoos KL, Mullikin JC, Noroski LM, Besse C, Wulffraat NM, Ferster A, Abecasis MM, Calvo F, Petit C, Candotti F, Abel L, Fischer A, Cavazzana-Calvo M.

Nat Genet. 2009 Jan;41(1):106-11. doi: 10.1038/ng.278. Epub 2008 Nov 30.

3.
4.

Use of hematopoietic progenitor cell count on the Sysmex XE-2100 for peripheral blood stem cell harvest monitoring.

Letestu R, Marzac C, Audat F, Belhocine R, Tondeur S, Baccini V, Garçon L, Cortivo LD, Perrot JY, Lefrère F, Valensi F, Ajchenbaum-Cymbalista F.

Leuk Lymphoma. 2007 Jan;48(1):89-96.

PMID:
17327950
5.

Deciphering leukemic B-cell chronic lymphoproliferative disorders.

Ugo V, Leporrier N, Salaun V, Letestu R, Radford-Weiss I, Ramond S, Nataf J, Guesnu M, Picard F, Brouzes C, Perrot JY, Valensi F, Levy V, Ajchenbaum-Cymbalista F, Troussard X.

Leuk Lymphoma. 2006 Oct;47(10):2088-95.

PMID:
17071481
6.

[Acute megakaryoblastic leukemia (AML-7) in a woman of 95 years].

Smadja DM, Gisselbrecht M, Valensi F, Mossafa H, Darnige L.

Ann Biol Clin (Paris). 2006 Mar-Apr;64(2):173-6. French.

7.

Severe human herpesvirus-8 primary infection in a renal transplant patient successfully treated with anti-CD20 monoclonal antibody.

Thaunat O, Mamzer-Bruneel MF, Agbalika F, Valensi F, Venditto M, Lebbe C, Frances C, Kania R, Chatenoud L, Antoine C, Kaveri S, Kreis H, Morelon E.

Blood. 2006 Apr 1;107(7):3009-10. No abstract available.

8.

[Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].

Diop S, Letestu R, Orsolani D, Leboeuf Y, Le Tutour P, Thiam D, Diakhate L, Valensi F.

Dakar Med. 2005;50(2):65-8. French.

PMID:
16295759
9.

DEK-CAN molecular monitoring of myeloid malignancies could aid therapeutic stratification.

Garçon L, Libura M, Delabesse E, Valensi F, Asnafi V, Berger C, Schmitt C, Leblanc T, Buzyn A, Macintyre E.

Leukemia. 2005 Aug;19(8):1338-44.

PMID:
15973457
10.

Absence or low expression of fas-associated protein with death domain in acute myeloid leukemia cells predicts resistance to chemotherapy and poor outcome.

Tourneur L, Delluc S, Lévy V, Valensi F, Radford-Weiss I, Legrand O, Vargaftig J, Boix C, Macintyre EA, Varet B, Chiocchia G, Buzyn A.

Cancer Res. 2004 Nov 1;64(21):8101-8.

11.

IgH DJ rearrangements within T-ALL correlate with cCD79a expression, an immature/TCRgammadelta phenotype and absence of IL7Ralpha/CD127 expression.

Asnafi V, Beldjord K, Garand R, Millien C, Bahloul M, LeTutour P, Douay L, Valensi F, Macintyre E.

Leukemia. 2004 Dec;18(12):1997-2001.

PMID:
15483677
12.

Fludarabine therapy in patients with splenic lymphoma with villous lymphocytes: an update.

Lefrère F, Lévy V, François S, Delarue R, Ifrah N, Tilly H, Valensi F, Troussard X, Varet B, Hermine O.

Leukemia. 2004 Nov;18(11):1924-5. No abstract available.

PMID:
15385943
13.

Plasma-cell leukemia and human herpesvirus 8 infection.

Duprez R, Lacoste V, Hermouet S, Troussard X, Valensi F, Merle-Beral H, Gessain A.

Leukemia. 2004 Nov;18(11):1903-4. No abstract available.

PMID:
15385930
14.

Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?

Saadoun D, Suarez F, Lefrere F, Valensi F, Mariette X, Aouba A, Besson C, Varet B, Troussard X, Cacoub P, Hermine O.

Blood. 2005 Jan 1;105(1):74-6. Epub 2004 Sep 7.

15.

Hemophagocytic syndrome as a presenting sign of transformation of smoldering to acute adult T-cell leukemia/lymphoma: efficacy of anti-retroviral and interferon therapy.

Aouba A, Lambotte O, Vasiliu V, Divine M, Valensi F, Varet B, Bazarbachi A, Hermine O.

Am J Hematol. 2004 Jun;76(2):187-9.

16.

Human T-cell leukaemia/lymphoma virus type 1-associated infective dermatitis in Africa: a report of five cases from Senegal.

Mahé A, Meertens L, Ly F, Sow PS, Diop CT, Samb ND, Diop OM, Valensi F, Gessain A.

Br J Dermatol. 2004 May;150(5):958-65.

PMID:
15149509
17.

Prognostic impact of p27KIP1 expression in cyclin D1 positive lymphoproliferative disorders.

Letestu R, Ugo V, Valensi F, Radford-Weiss I, Nataf J, Lévy V, Gribben JG, Troussard X, Ajchenbaum-Cymbalista F.

Leukemia. 2004 May;18(5):953-61.

PMID:
15029207
18.

[Bone marrow aspiration for diagnostic purposes].

Letestu R, Valensi F.

Ann Biol Clin (Paris). 2003 Nov-Dec;61(6):655-65. Review. French.

19.

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.

Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborne CS, Pawliuk R, Morillon E, Sorensen R, Forster A, Fraser P, Cohen JI, de Saint Basile G, Alexander I, Wintergerst U, Frebourg T, Aurias A, Stoppa-Lyonnet D, Romana S, Radford-Weiss I, Gross F, Valensi F, Delabesse E, Macintyre E, Sigaux F, Soulier J, Leiva LE, Wissler M, Prinz C, Rabbitts TH, Le Deist F, Fischer A, Cavazzana-Calvo M.

Science. 2003 Oct 17;302(5644):415-9. Erratum in: Science. 2003 Oct 24;302(5645):568.

20.

CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells.

Jacob MC, Chaperot L, Mossuz P, Feuillard J, Valensi F, Leroux D, Béné MC, Bensa JC, Brière F, Plumas J.

Haematologica. 2003 Aug;88(8):941-55.

21.

Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment.

Asnafi V, Beldjord K, Boulanger E, Comba B, Le Tutour P, Estienne MH, Davi F, Landman-Parker J, Quartier P, Buzyn A, Delabesse E, Valensi F, Macintyre E.

Blood. 2003 Apr 1;101(7):2693-703. Epub 2002 Nov 21.

22.

M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH).

Roumier C, Eclache V, Imbert M, Davi F, MacIntyre E, Garand R, Talmant P, Lepelley P, Lai JL, Casasnovas O, Maynadie M, Mugneret F, Bilhou-Naberra C, Valensi F, Radford I, Mozziconacci MJ, Arnoulet C, Duchayne E, Dastugue N, Cornillet P, Daliphard S, Garnache F, Boudjerra N, Jouault H, Fenneteau O, Pedron B, Berger R, Flandrin G, Fenaux P, Preudhomme C; Groupe Francais de Cytogenetique Hematologique (GFCH); Groupe Français d'Hématologie Cellulaire (GFHC).

Blood. 2003 Feb 15;101(4):1277-83. Epub 2002 Oct 10.

23.

all-trans-Retinoic acid in the treatment of Kimura's disease.

Boulanger E, Gachot B, Verkarre V, Valensi F, Brousse N, Hermine O.

Am J Hematol. 2002 Sep;71(1):66. No abstract available.

24.

Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection.

Hermine O, Lefrère F, Bronowicki JP, Mariette X, Jondeau K, Eclache-Saudreau V, Delmas B, Valensi F, Cacoub P, Brechot C, Varet B, Troussard X.

N Engl J Med. 2002 Jul 11;347(2):89-94.

25.

Remission of transformed myelodysplastic syndrome with fibrosis after danazol therapy.

Damaj G, Lefrère F, Canioni D, Rubio MT, Radford-Weiss I, Valensi F, Varet B, Hermine O.

Eur J Haematol. 2002 Apr;68(4):233-5.

PMID:
12071939
26.

Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study.

Lefrère F, Delmer A, Suzan F, Levy V, Belanger C, Djabarri M, Arnulf B, Damaj G, Maillard N, Ribrag V, Janvier M, Sebban C, Casasnovas RO, Bouabdallah R, Dreyfus F, Verkarre V, Delabesse E, Valensi F, McIntyre E, Brousse N, Varet B, Hermine O.

Leukemia. 2002 Apr;16(4):587-93.

27.

Clinical and biologic features of CD4(+)CD56(+) malignancies.

Feuillard J, Jacob MC, Valensi F, Maynadié M, Gressin R, Chaperot L, Arnoulet C, Brignole-Baudouin F, Drénou B, Duchayne E, Falkenrodt A, Garand R, Homolle E, Husson B, Kuhlein E, Le Calvez G, Sainty D, Sotto MF, Trimoreau F, Béné MC.

Blood. 2002 Mar 1;99(5):1556-63.

28.

Recurrence of OTT-MAL fusion in t(1;22) of infant AML-M7.

Mercher T, Busson-Le Coniat M, Nguyen Khac F, Ballerini P, Mauchauffé M, Bui H, Pellegrino B, Radford I, Valensi F, Mugneret F, Dastugue N, Bernard OA, Berger R.

Genes Chromosomes Cancer. 2002 Jan;33(1):22-8.

PMID:
11746984
29.

A multicentric study of 41 cases of B-prolymphocytic leukemia: two evolutive forms.

Hercher C, Robain M, Davi F, Garand R, Flandrin G, Valensi F, Vandeputte H, Albert A, Maynadie M, Troussard X, Simon GH, Lespinasse J, Portefaix G, Merle-Beral H; Groupe Français d'Hématologie Cellulaire.

Leuk Lymphoma. 2001 Sep-Oct;42(5):981-7.

PMID:
11697653
30.

Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype.

Bernard M, Gressin R, Lefrère F, Drénou B, Branger B, Caulet-Maugendre S, Tass P, Brousse N, Valensi F, Milpied N, Voilat L, Sadoun A, Ghandour C, Hunault M, Leloup R, Mannone L, Hermine O, Lamy T.

Leukemia. 2001 Nov;15(11):1785-91.

PMID:
11681422
31.

Lack of efficacy of 2-chlorodeoxyadenoside in the treatment of splenic lymphoma with villous lymphocytes.

Lefrère F, Hermine O, François S, Panelatti G, Valensi F, Grosbois B, Misset JL, Varet B, Troussard X.

Leuk Lymphoma. 2000 Dec;40(1-2):113-7.

PMID:
11426611
32.

Caspase activation is required for terminal erythroid differentiation.

Zermati Y, Garrido C, Amsellem S, Fishelson S, Bouscary D, Valensi F, Varet B, Solary E, Hermine O.

J Exp Med. 2001 Jan 15;193(2):247-54.

33.

Association of acute neutrophilic dermatosis and myelodysplastic syndrome with (6; 9) chromosome translocation: a case report and review of the literature.

Mégarbane B, Bodemer C, Valensi F, Radford-Weiss I, Fraitag S, MacIntyre E, Bletry O, Varet B, Hermine O.

Br J Dermatol. 2000 Dec;143(6):1322-4. Review. No abstract available.

PMID:
11122045
34.

Transforming growth factor inhibits erythropoiesis by blocking proliferation and accelerating differentiation of erythroid progenitors.

Zermati Y, Fichelson S, Valensi F, Freyssinier JM, Rouyer-Fessard P, Cramer E, Guichard J, Varet B, Hermine O.

Exp Hematol. 2000 Aug;28(8):885-94.

PMID:
10989189
35.

The incidence of clonal T-cell receptor rearrangements in B-cell precursor acute lymphoblastic leukemia varies with age and genotype.

Brumpt C, Delabesse E, Beldjord K, Davi F, Cayuela JM, Millien C, Villarese P, Quartier P, Buzyn A, Valensi F, Macintyre E.

Blood. 2000 Sep 15;96(6):2254-61.

36.

Rapid, multifluorescent TCRG Vgamma and Jgamma typing: application to T cell acute lymphoblastic leukemia and to the detection of minor clonal populations.

Delabesse E, Burtin ML, Millien C, Madonik A, Arnulf B, Beldjord K, Valensi F, Macintyre EA.

Leukemia. 2000 Jun;14(6):1143-52.

PMID:
10865981
37.

Virological and molecular characterisation of a new B lymphoid cell line, established from an AIDS patient with primary effusion lymphoma, harbouring both KSHV/HHV8 and EBV viruses.

Lacoste V, Judde JG, Bestett G, Cadranel J, Antoine M, Valensi F, Delabesse E, Macintyre E, Gessain A.

Leuk Lymphoma. 2000 Jul;38(3-4):401-9.

PMID:
10830748
38.

Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytes.

Lefrère F, Hermine O, Belanger C, François S, Tilly H, Lebas de La Cour JC, Valensi F, Varet B, Troussard X.

Leukemia. 2000 Apr;14(4):573-5.

PMID:
10764141
39.

NG2 expression in MLL rearranged acute myeloid leukaemia is restricted to monoblastic cases.

Mauvieux L, Delabesse E, Bourquelot P, Radford-Weiss I, Bennaceur A, Flandrin G, Valensi F, MacIntyre EA.

Br J Haematol. 1999 Dec;107(3):674-6.

PMID:
10583275
40.

Persistent polyclonal B lymphocytosis with binucleated lymphocytes: a study of 25 cases. Groupe Français d'Hématologie Cellulaire.

Mossafa H, Malaure H, Maynadie M, Valensi F, Schillinger F, Garand R, Jung G, Flandrin G, Troussard X.

Br J Haematol. 1999 Mar;104(3):486-93.

PMID:
10086784
41.

FISH detection of chromosome 14q32/IgH translocations: evaluation in follicular lymphoma.

Rack KA, Salomon-Nguyen F, Radford-Weiss I, Gil MO, Schmitt C, Belanger C, Nusbaum S, Vekemans M, Valensi F, Macintyre EA.

Br J Haematol. 1998 Nov;103(2):495-504.

PMID:
9827925
42.

TAL1 expression does not occur in the majority of T-ALL blasts.

Delabesse E, Bernard M, Meyer V, Smit L, Pulford K, Cayuela JM, Ritz J, Bourquelot P, Strominger JL, Valensi F, Macintyre EA.

Br J Haematol. 1998 Jul;102(2):449-57.

PMID:
9695959
43.

Genetic analysis of splenic lymphoma with villous lymphocytes: a Groupe Français d'Hématologie Cellulaire (GFHC) study.

Troussard X, Mauvieux L, Radford-Weiss I, Rack K, Valensi F, Garand R, Vekemans M, Flandrin G, Macintyre EA.

Br J Haematol. 1998 Jun;101(4):712-21.

PMID:
9674745
44.

Severe aplastic anemia of neonatal onset: a single-center retrospective study of six children.

Aladjidi N, Casanova JL, Canioni D, Valensi F, Brousse N, Blanche S, Fischer A.

J Pediatr. 1998 Apr;132(4):600-5.

PMID:
9580756
45.
46.

Simultaneous SIL-TAL1 RT-PCR detection of all tal(d) deletions and identification of novel tal(d) variants.

Delabesse E, Bernard M, Landman-Parker J, Davi F, Leboeuf D, Varet B, Valensi F, Macintyre EA.

Br J Haematol. 1997 Dec;99(4):901-7.

PMID:
9432040
47.

Quantitative RNA slot-blot analysis of CCND1/cyclin D1 expression in suspected mantle cell lymphoma.

Mauvieux L, Canioni D, Hermine O, Valensi F, Radford-Weiss I, Azagury M, Magen M, Flandrin G, Brousse N, Varet B, Macintyre EA.

Leukemia. 1998 Jan;12(1):78-85.

PMID:
9436924
48.

The majority of myeloid-antigen-positive (My+) childhood B-cell precursor acute lymphoblastic leukaemias express TEL-AML1 fusion transcripts.

Baruchel A, Cayuela JM, Ballerini P, Landman-Parker J, Cezard V, Firat H, Haddad E, Auclerc MF, Valensi F, Cayre YE, Macintyre EA, Sigaux F.

Br J Haematol. 1997 Oct;99(1):101-6.

PMID:
9359509
49.

Alternative origin of p13MTCP1-encoding transcripts in mature T-cell proliferations with t(X;14) translocations.

Gritti C, Choukroun V, Soulier J, Madani A, Dastot H, Leblond V, Radford-Weiss I, Valensi F, Varet B, Sigaux F, Stern MH.

Oncogene. 1997 Sep;15(11):1329-35.

50.

[Polyclonal lymphocytosis with binucleated lymphocytes. Morphological, immunological, cytogenetic and molecular analysis in 15 cases].

Troussard X, Mossafa H, Valensi F, Maynadie M, Schillinger F, Bulliard G, Malaure H, Flandrin G.

Presse Med. 1997 Jun 7;26(19):895-9. French.

PMID:
9232058

Supplemental Content

Loading ...
Support Center